 | Viracta Therapeutics, Inc. | |||
| NMS : VIRX || Location: United States | ||||
$0.86-0.05 (-5.49%) |
0.05 M | 0.82 - 0.91 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.648 M |
| March 15, 2024 | 0.634 M |
| Feb. 29, 2024 | 0.683 M |
| Feb. 15, 2024 | 0.679 M |
| Jan. 31, 2024 | 0.650 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.32 | -0.35 | -10.69% |
| 09/30/2023 | -0.31 | -0.33 | -6.08% |
| 06/30/2023 | -0.30 | -0.32 | -8.18% |
| 03/31/2023 | -0.32 | -0.32 | -0.38% |
| 12/31/2022 | -0.39 | -0.27 | 31.25% |
VIRX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 39.272M | Shares Float | 24.552M |
| Short Float | 0.648M | Market Cap | 35.74M |
| Institution ownership | 52.79% | Insider ownership | 2.884% |
| Earnings Date | 05/07/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -1.32 | Forward EPS | -1.21 |